BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1 | SAM.gov Opportunity | G2X

BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1

SolicitationHT9425-23-S-SOC1-0003Notice typeSpecial Notice

Attachments

5 files

Name	Type	Posted	Actions
HT9425-23-S-SOC1.pdf	PDF	Jul 23, 2025	Download
HT9425-23-S-SOC1-0001.pdf	PDF	Jul 23, 2025	Download
https://grants.gov/home	LINK	Jul 23, 2025	Download
HT9425-23-S-SOC1-0002.pdf	PDF	Jul 23, 2025	Download
HT9425-23-S-SOC1-0003.pdf	PDF	Jul 23, 2025	Download

Version History

BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1

Special NoticeHT9425-23-S-SOC1-0003Jul 23, 2025 · v1

LatestViewing

Opportunity Summary

The Defense Health Agency, through the Army Medical Research Acquisition Activity, is soliciting extramural research and development ideas under a Broad Agency Announcement for biomedical and human performance initiatives. This special notice, identified as solicitation HT9425-23-S-SOC1-0003, focuses on basic and applied research intended to advance the state-of-the-art or increase scientific understanding rather than developing specific hardware solutions. The program supports United States Special Operations Command research areas of interest, with the expectation that funded projects will benefit both military and civilian medical practices. The opportunity is classified under PSC AN12 for Health R&D Services; Health Care Services; Applied Research and has no set-aside designation.

This procurement follows a multi-step submission process. Interested parties must first submit a pre-proposal through the electronic Biomedical Research Application Portal. If the government expresses interest, the Principal Investigator will be invited to submit a full proposal or application via Grants.gov. The solicitation is supported by five attachments, including the primary announcement and general submission instructions. The CDMRP Help Desk serves as the point of contact for this notice.

The Broad Agency Announcement remains continuously open for a five-year period through July 31, 2028, with a final response deadline of August 1, 2028. Pre-proposals may be submitted at any time during this performance window. Administrative details, including evaluation criteria and specific research areas of interest, are outlined within the solicitation documentation available on federal portals.

Generated by Lumen AI

Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.

Opportunity Summary

Opportunity Details

Response deadline: Aug 1, 2028777 days remaining
NAICS: —
PSC: AN12 (opens in new tab)
Set aside: NONE
Published: Jul 23, 2025
Updated: Jul 23, 2025
Agency: DEFENSE HEALTH AGENCY (DHA) (opens in new tab)
Office: ARMY MED RES ACQ ACTIVITY
Department: —
Source: View on SAM.gov (opens in new tab)

Contact and place of performance

Point of contact: CDMRP Help Desk

Place of performance: Not specified

Original Description

This BAA is intended to solicit extramural research and development ideas using the authority provided by United States Code, Title 10, Section 4001. This BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in Federal Acquisition Regulation 6.102(d) (2) and 35.016. In accordance with FAR 6.102, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funding through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge. This BAA provides a general description of USSOCOM's research and development programs, including research areas of interest, evaluation and selection criteria, pre-proposal/pre-application and full proposal/application preparation instructions, and general administrative information. Submission of a pre-proposal is required. After review, if the USSOCOM is interested in receiving a full proposal, the Offeror will be invited to submit a full proposal or full application. Specific submission information and additional administrative requirements can be found in the document titled "General Submission Instructions" available in Grants.gov along with this BAA The BAA is continuously open for a 5-year period, from 01 August 2023 through 31 July 2028, at 11:59 p.m. Eastern Time. Submission of a pre-proposal is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/). Preproposals may be submitted at any time throughout the 5-year period. If the USSOCOM is interested in receiving a full proposal/application, the Principal Investigator will be sent an invitation to submit via eBRAP. A full proposal/application must be submitted through Grants.gov (http://www.grants.gov/). Invited full proposals/applications can be submitted under this BAA through 31 July 2028. The BAA with revised research areas of interests, and General Submission Instructions is available for download on Grants.gov. Search opportunity number HT9425-23-S-SOC1.